These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 625191

  • 1. Effect of psychotropic drugs on 3,4-dihydroxyphenylacetic acid (DOPAC) content in the medial basal hypothalamus.
    Argiolas A, Paglietti E, Fadda F, Quarantotti BP, Gessa GL.
    Life Sci; 1978 Feb; 22(6):461-6. PubMed ID: 625191
    [No Abstract] [Full Text] [Related]

  • 2. Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus.
    Fadda F, Argiolas A, Stefanini E, Gessa GL.
    Life Sci; 1977 Aug 01; 21(3):411-7. PubMed ID: 895373
    [No Abstract] [Full Text] [Related]

  • 3. Reduction by beta-endorphin of efflux of dopamine and DOPAC from superfused medial basal hypothalamus.
    Wilkes MM, Yen SS.
    Life Sci; 1980 Oct 13; 27(15):1387-91. PubMed ID: 6255276
    [No Abstract] [Full Text] [Related]

  • 4. Changes in dopamine and DOPAC following systemic administration of apomorphine and 3,4-dihydroxyphenylamino-2-imidazoline (DPI) in rats.
    Springer J, Hannigan JH, Isaacson RL.
    Brain Res; 1981 Sep 07; 220(1):226-30. PubMed ID: 7272755
    [Abstract] [Full Text] [Related]

  • 5. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y, Komori T, Okuda S, Segawa T.
    Arch Int Pharmacodyn Ther; 1979 Jan 07; 237(1):25-30. PubMed ID: 485682
    [Abstract] [Full Text] [Related]

  • 6. Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental area.
    Argiolas A, Fadda F, Melis MR, Serra G, Gessa GL.
    Brain Res; 1979 Oct 12; 175(1):178-82. PubMed ID: 487148
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of neuroleptics on the content of dopamine and DOPAC in the caudate nucleus of the rat].
    Gérardy J, Dresse A.
    Experientia; 1974 May 15; 30(5):523-4. PubMed ID: 4833680
    [No Abstract] [Full Text] [Related]

  • 8. Apomorphine- and haloperidol-induced change in 3,4-dihydroxyphenylacetic acid content in the mesolimbic-striatum of the developing rat.
    Nomura Y, Oki K, Segawa T.
    J Pharmacobiodyn; 1980 Feb 15; 3(2):111-6. PubMed ID: 7205536
    [Abstract] [Full Text] [Related]

  • 9. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG, Roth RH.
    Brain Res; 1981 Feb 02; 205(2):313-9. PubMed ID: 7470869
    [Abstract] [Full Text] [Related]

  • 10. Haloperidol increases DOPAC in the substantia nigra but not in the ventral tegmental area.
    Argiolas A, Fadda F, Melis MR, Gessa GL.
    Life Sci; 1979 Jun 11; 24(24):2279-84. PubMed ID: 502748
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine, noradrenaline and 3,4-dihydroxyphenylacetic acid (DOPAC) levels of individual brain nuclei, effects of haloperidol and pargyline.
    Fekete MI, Herman JP, Kanyicska B, Palkovits M.
    J Neural Transm; 1979 Jun 11; 45(3):207-18. PubMed ID: 479873
    [Abstract] [Full Text] [Related]

  • 12. Yawning behavior in male rats is associated with decreases in in vivo DOPAC efflux from the caudate nucleus.
    Laping NJ, Ramirez VD.
    Behav Brain Res; 1990 Jan 01; 36(1-2):65-72. PubMed ID: 2302322
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus.
    Tonon G, Saiani L, Spano PF, Trabucchi M.
    Brain Res; 1979 Jan 19; 160(3):553-8. PubMed ID: 217486
    [No Abstract] [Full Text] [Related]

  • 15. Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo.
    Mohankumar PS, Thyagarajan S, Quadri SK.
    Life Sci; 1991 Jan 19; 48(9):925-30. PubMed ID: 1997793
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.